Serum S100A6 Concentration Predicts Peritoneal Tumor Burden in Mice with Epithelial Ovarian Cancer and Is Associated with Advanced Stage in Patients

• Bih-Rong Wei,

  Affiliation Molecular Pathology Unit, Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Shelley B. Hoover,

  Affiliation Molecular Pathology Unit, Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Mark M. Ross,

  Affiliation Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, Virginia, United States of America

  ⨯
• Weidong Zhou,

  Affiliation Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, Virginia, United States of America

  ⨯
• Francesco Meani,

  Affiliation University of Brescia, Brescia, Italy

  ⨯
• Jennifer B. Edwards,

  Affiliation Molecular Pathology Unit, Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Elizabeth I. Spehalski,

  Current address: Department of Molecular and Cellular Pathology, University of Michigan College of Medicine, Ann Arbor, Michigan, United States of America

  Affiliation Molecular Pathology Unit, Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• John I. Risinger,

  Current address: Department of Obstetrics, Gynecology and Reproductive Biology, Michigan State University College of Human Medicine, Grand Rapids, Michigan, United States of America

  Affiliation Anderson Cancer Institute, Memorial Health University Medical Center, Inc., Savannah, Georgia, United States of America

  ⨯
• W. Gregory Alvord,

  Affiliation Data Management Services, Inc., National Cancer Institute, Frederick, Maryland, United States of America

  ⨯
• Octavio A. Quiñones,

  Affiliation Data Management Services, Inc., National Cancer Institute, Frederick, Maryland, United States of America

  ⨯
• Claudio Belluco,

  Affiliations Centro di Riferimento Oncologico, IRCCS, National Cancer Institute, Aviano, Italy, Department of Haematology, Oncology, and Molecular Medicine, Istituto Superiore di Sanita, Rome, Italy

  ⨯
• Luca Martella,

  Affiliation Centro di Riferimento Oncologico, IRCCS, National Cancer Institute, Aviano, Italy

  ⨯
• Elio Campagnutta,

  Affiliation Centro di Riferimento Oncologico, IRCCS, National Cancer Institute, Aviano, Italy

  ⨯
• Antonella Ravaggi,

  Affiliation University of Brescia, Brescia, Italy

  ⨯
• Ren-Ming Dai,

  Current address: Laboratory of Experimental Immunology, NCI Frederick, Frederick, Maryland, United States of America

  Affiliation Molecular Pathology Unit, Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Paul K. Goldsmith,

  Affiliation Antibody and Protein Purification Unit, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Kevin D. Woolard,

  Current address: Neuro-Oncology Branch, Center for Cancer Research, NCI, Bethesda, Maryland, United States of America

  Affiliation Molecular Pathology Unit, Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Sergio Pecorelli,

  Affiliation University of Brescia, Brescia, Italy

  ⨯
• Lance A. Liotta,

  Affiliation Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, Virginia, United States of America

  ⨯
• Emanuel F. Petricoin III,

  Affiliation Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, Virginia, United States of America

  ⨯
•  [ ... ],
• R. Mark Simpson

  * E-mail: ms43b@nih.gov

  Affiliation Molecular Pathology Unit, Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• [ view all ]
• [ view less ]